Comparison of Immune Response Following Surgical Management of Renal Tumors
NCT00289146 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2013-09-24
Summary
Examine the effects of renal surgery on the immune system.
Conditions
Sponsors & Collaborators
-
Emory University
lead OTHER
Principal Investigators
-
Kenneth Ogan, MD · Emory University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-11-30
- Primary Completion
- 2006-08-31
- Completion
- 2006-08-31
Countries
- United States
Study Locations
More Related Trials
-
Epidemiological Study on Malignancy Complicated With Renal Injury
NCT05392725 ·Status: UNKNOWN
-
Serological Autoantibodies in Early Kidney Cancer Diagnosis and Prognosis: A Multicenter Study
NCT06917560 ·Status: ACTIVE_NOT_RECRUITING
-
Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms
NCT01390597 ·Status: COMPLETED
-
Target Gene Sequencing for Advanced Stage, Relapsed or Refractory Natural Killer/T-cell Lymphoma
NCT04509804 ·Status: COMPLETED
-
Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study
NCT06883565 ·Status: COMPLETED
-
Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC
NCT02143492 ·Status: COMPLETED
-
Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy
NCT05112627 ·Status: COMPLETED
-
The Association of Marital Status With Kidney Cancer Surgery Morbidity
NCT05526599 ·Status: COMPLETED
-
Evaluation of Diagnostic Value of Molecular Markers in Renal Cancer
NCT00491621 ·Status: TERMINATED ·Phase: NA
-
Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer
NCT04883827 ·Status: COMPLETED
-
(COVID-19) Longitudinal Neutralizing Antibody Titers in Cancer Patients Receiving Different Anti-caner Therapies
NCT05384509 ·Status: RECRUITING
-
Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms Tumor
NCT01314391 ·Status: COMPLETED
-
Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer.
NCT05083494 ·Status: UNKNOWN
-
Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney Cancer
NCT00899860 ·Status: TERMINATED
-
Analysis of Biomarkers in Lymph Node Tissue
NCT04228796 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Kidney Tumors in Younger Patients
NCT00898365 ·Status: COMPLETED
-
Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
NCT02948946 ·Status: COMPLETED
-
Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma
NCT00026910 ·Status: COMPLETED
-
Evaluation of Preexisting Immunity Markers in Human Tumor Tissue Sample
NCT00568867 ·Status: COMPLETED
-
Tumor Immunity and Cancer Recurrence Prediction Model
NCT06855290 ·Status: NOT_YET_RECRUITING
-
Biomarkers in Urine Samples From Patients With Wilms Tumor
NCT01550393 ·Status: COMPLETED
-
Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer
NCT00806650 ·Status: COMPLETED
-
Improved Assessment of Response in Metastatic Renal Cell Carcinoma Using Spectral-CT
NCT03616951 ·Status: UNKNOWN
-
Molecular Analysis in Tissue Samples From Patients With Advanced or Metastatic Neuroendocrine Tumors
NCT02092714 ·Status: UNKNOWN
-
ctDNA-MRD Monitoring After Resection in Gastric Cancer
NCT06893133 ·Status: RECRUITING